PDZK1 protects against mechanical overload-induced chondrocyte senescence and osteoarthritis by targeting mitochondrial function

Abstract

Mechanical overloading and aging are two essential factors for osteoarthritis (OA) development. Mitochondria have been identified as a mechano-transducer situated between extracellular mechanical signals and chondrocyte biology, but their roles and the associated mechanisms in mechanical stress-associated chondrocyte senescence and OA have not been elucidated. Herein, we found that PDZ domain containing 1 (PDZK1), one of the PDZ proteins, which belongs to the Na⁺/H⁺ Exchanger (NHE) regulatory factor family, is a key factor in biomechanically induced mitochondrial dysfunction and chondrocyte senescence during OA progression. PDZK1 is reduced by mechanical overload, and is diminished in the articular cartilage of OA patients, aged mice and OA mice. Pdzk1 knockout in chondrocytes exacerbates mechanical overload-induced cartilage degeneration, whereas intraarticular injection of adeno-associated virus-expressing PDZK1 had a therapeutic effect. Moreover, PDZK1 loss impaired chondrocyte mitochondrial function with accumulated damaged mitochondria, decreased mitochondrion DNA (mtDNA) content and increased reactive oxygen species (ROS) production. PDZK1 supplementation or mitoubiquinone (MitoQ) application alleviated chondrocyte senescence and cartilage degeneration and significantly protected chondrocyte mitochondrial functions. MRNA sequencing in articular cartilage from Pdzk1 knockout mice and controls showed that PDZK1 deficiency in chondrocytes interfered with mitochondrial function through inhibiting Hmgcs2 by increasing its ubiquitination. Our results suggested that PDZK1 deficiency plays a crucial role in mediating excessive mechanical load-induced chondrocyte senescence and is associated with mitochondrial dysfunction. PDZK1 overexpression or preservation of mitochondrial functions by MitoQ might present a new therapeutic approach for mechanical overload-induced OA.

References

[1] Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet, 2019, 393: 1745-1759

[2] Sharma L. Osteoarthritis of the Knee. N. Engl. J. Med., 2021, 384: 51-59

[3] Glyn-Jones S et al. Osteoarthritis. Lancet, 2015, 386: 376-387

[4] Visser AW et al. The relative contribution of mechanical stress and systemic processes in different types of osteoarthritis: the NEO study. Ann. Rheum. Dis., 2015, 74: 1842-1847

[5] Coryell PR, Diekman BO, Loeser RF. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat. Rev. Rheumatol., 2021, 17: 47-57

[6] Rose J et al. DNA damage, discoordinated gene expression and cellular senescence in osteoarthritic chondrocytes. Osteoarthr. Cartil., 2012, 20: 1020-1028

[7] Zhang H et al. Mechanical overloading promotes chondrocyte senescence and osteoarthritis development through downregulating FBXW7. Ann. Rheum. Dis., 2022, 81: 676-686

[8] Griffin, T. M. & Guilak, F. The role of mechanical loading in the onset and progression of osteoarthritis. Exerc. Sport Sci. Rev. 33, 195 (2005).

[9] Yuan XL et al. Bone-cartilage interface crosstalk in osteoarthritis: potential pathways and future therapeutic strategies. Osteoarthr. Cartil., 2014, 22: 1077-1089

[10] Zhang Y et al. Primary cilium-mediated mechanotransduction in cartilage chondrocytes. Exp. Biol. Med., 2023, 248: 1279-1287

[11] Silva-Pinheiro P, Minczuk M. The potential of mitochondrial genome engineering. Nat. Rev. Genet, 2022, 23: 199-214

[12] Chan DC. Mitochondrial dynamics and its involvement in disease. Annu Rev. Pathol., 2020, 15: 235-259

[13] Gorman GS et al. Mitochondrial diseases. Nat. Rev. Dis. Prim., 2016, 2

[14] Valdes AM, Goldring MB. Mitochondrial DNA haplogroups and ageing mechanisms in osteoarthritis. Ann. Rheum. Dis., 2017, 76: 939-941

[15] Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev., 2014, 94: 909-950

[16] Cleveland KH, Schnellmann RG. Pharmacological targeting of mitochondria in diabetic kidney disease. Pharm. Rev., 2023, 75: 250-262

[17] Reed KN, Wilson G, Pearsall A, Grishko VI. The role of mitochondrial reactive oxygen species in cartilage matrix destruction. Mol. Cell Biochem., 2014, 397: 195-201

[18] Li, H. et al. Reprogramming macrophage polarization, depleting ROS by astaxanthin and thioketal-containing polymers delivering rapamycin for osteoarthritis treatment. Adv. Sci. (2023).

[19] Goetz JE et al. Time-dependent loss of mitochondrial function precedes progressive histologic cartilage degeneration in a rabbit meniscal destabilization model. J. Orthop. Res., 2017, 35: 590-599

[20] Bartell LR et al. Mitoprotective therapy prevents rapid, strain-dependent mitochondrial dysfunction after articular cartilage injury. J. Orthop. Res., 2020, 38: 1257-1267

[21] Barrett-Jolley R, Lewis R, Fallman R, Mobasheri A. The emerging chondrocyte channelome. Front. Physiol., 2010, 1: 135

[22] Kefauver JM, Ward AB, Patapoutian A. Discoveries in structure and physiology of mechanically activated ion channels. Nature, 2020, 587: 567-576

[23] Mobasheri A et al. The chondrocyte channelome: A narrative review. Jt. Bone Spine, 2019, 86: 29-35

[24] Milner, P. I., Wilkins, R. J. & Gibson, J. S. The role of mitochondrial reactive oxygen species in pH regulation in articular chondrocytes. Osteoarthr. Cartil. 15, 735–742 (2007).

[25] Hopwood, B., Tsykin, A., Findlay, D. M. & Fazzalari, N. L. Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signalling. Arthritis Res. Ther. 9, R100 (2007).

[26] Donowitz, M. et al. NHERF family and NHE3 regulation. J. Physiol. 567, 3–11 (2005)

[27] Jiang W et al. Mechanisms linking mitochondrial mechanotransduction and chondrocyte biology in the pathogenesis of osteoarthritis. Ageing Res. Rev., 2021, 67

[28] Chazotte, B. Labeling mitochondria with JC-1. Cold Spring Harb. Protoc. 2011, https://doi.org/10.1101/pdb.prot065490 (2011).

[29] Kim H et al. Correlation between PDZK1, Cdc37, Akt and breast cancer malignancy: the role of PDZK1 in cell growth through Akt stabilization by increasing and interacting with Cdc37. Mol. Med., 2014, 20: 270-279

[30] Bolduc JA, Collins JA, Loeser RF. Reactive oxygen species, aging and articular cartilage homeostasis. Free Radic. Biol. Med, 2019, 132: 73-82

[31] Chang SH et al. Excessive mechanical loading promotes osteoarthritis through the gremlin-1-NF-κB pathway. Nat. Commun., 2019, 10

[32] Jiang W et al. Mechanical stress abnormalities promote chondrocyte senescence - The pathogenesis of knee osteoarthritis. Biomed. Pharmacother., 2023, 167

[33] Qi Y et al. Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation. Oncogene, 2020, 39: 4404-4420

[34] Zheng J et al. Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma. EBioMedicine, 2017, 15: 62-72

[35] Cha B et al. PDZ domain-dependent regulation of NHE3 protein by both internal Class II and C-terminal Class I PDZ-binding motifs. J. Biol. Chem., 2017, 292: 8279-8290

[36] Zhao C et al. Loss of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer. Cancer Lett., 2019, 453: 107-121

[37] Puchalska P, Crawford PA. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab., 2017, 25: 262-284

[38] Bai M et al. LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO Mol. Med., 2023, 15

[39] Culley KL et al. Mouse models of osteoarthritis: surgical model of post-traumatic osteoarthritis induced by destabilization of the medial meniscus. Methods Mol. Biol., 2021, 2221: 223-260

[40] Tizro P, Choi C, Khanlou N. Sample preparation for transmission electron microscopy. Methods Mol. Biol., 2019, 1897: 417-424

Funding

National Natural Science Foundation of China (National Science Foundation of China)(82172491)

National Key Research and Development Program of China (2022YFC3601902)

State-funded postdoctoral researcher program No GZC20231062 (CN)

Youth Talent Support Programme of Guangdong Provincial Association for Science and Technology (SKXRC202308)